Colorectal Adenomas in a Randomized Folate Trial: The Role of Baseline Dietary and Circulating Folate Levels
Open Access
- 1 October 2008
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- Vol. 17 (10), 2625-2631
- https://doi.org/10.1158/1055-9965.epi-08-0382
Abstract
The Aspirin/Folate Polyp Prevention Study is a randomized, placebo-controlled trial of aspirin use and folic acid supplementation and incidence of colorectal adenomas in individuals with a history of these lesions. The trial showed that folic acid supplementation does not prevent the occurrence of new adenomas and may increase risk. We extend these results by investigating whether the effect of folic acid treatment differed by baseline dietary and circulating folate levels. Diet and supplement use were ascertained at baseline through a food-frequency questionnaire; a blood sample was used to determine plasma and RBC folate levels. Individuals were followed for 3 years (first follow-up) and subsequently for an additional 3 to 5 years (second follow up). We used generalized linear regression to estimate risk ratios and 95% confidence limits as measures of association. There was little evidence that baseline dietary and total folate intake, and plasma and RBC folate modified the association between folic acid treatment and risk of any adenomas or advanced lesions. However, there was a protective association of the highest tertile of dietary and total intake as well as circulating folate with risk of any adenomas among those in the placebo group but no association among individuals in the folic acid group. Our findings support the idea that although moderate doses of folate may be protective compared with deficiency, at some point of sufficiency, supplementation provides no additional benefit. (Cancer Epidemiol Biomarkers Prev 2008;17(10):2625–31)Keywords
This publication has 40 references indexed in Scilit:
- Measurement of Folate in Fresh and Archival Serum Samples as p-Aminobenzoylglutamate EquivalentsClinical Chemistry, 2008
- Responses of Biomarkers of Folate and Riboflavin Status to Folate and Riboflavin Supplementation in Healthy and Colorectal Polyp Patients (The FAB2 Study)Cancer Epidemiology, Biomarkers & Prevention, 2007
- Folate: a magic bullet or a double edged sword for colorectal cancer prevention?Gut, 2006
- Folate fortification, plasma folate, homocysteine and colorectal adenoma recurrenceInternational Journal of Cancer, 2006
- Folate, Vitamin B6, Multivitamin Supplements, and Colorectal Cancer Risk in WomenAmerican Journal of Epidemiology, 2005
- Folic Acid Food Fortification in CanadaNutrition Reviews, 2004
- Folic Acid Food Fortification in CanadaPublished by Oxford University Press (OUP) ,2004
- A Randomized Trial of Aspirin to Prevent Colorectal AdenomasNew England Journal of Medicine, 2003
- Effects of dietary folate on intestinal tumorigenesis in the APCMIN in mouseGastroenterology, 2000
- Markers of Mast Cell DegranulationMethods, 1997